VF
KURA icon

Virtu Financial’s Kura Oncology KURA Stock Holding History

Virtu Financial’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$249K Sell
30,615
-2,976
-9% -$25.6K 0.01% 910
2025
Q4 		$349K Buy
+33,591
New +$352K 0.01% 776
2025
Q3 		– Sell
-11,283
Closed -$65K – 1800
2025
Q2 		$65K Buy
+11,283
New +$69.1K ﹤0.01% 1105
2025
Q1 		– Sell
-15,912
Closed -$139K – 1711
2024
Q4 		$139K Buy
+15,912
New +$229K 0.01% 964
2023
Q3 		– Sell
-12,233
Closed -$129K – 1608
2023
Q2 		$129K Buy
+12,233
New +$145K 0.01% 953
2021
Q1 		– Sell
-9,753
Closed -$319K – 1825
2020
Q4 		$319K Buy
+9,753
New +$343K 0.03% 615
2017
Q4 		– Sell
-68,658
Closed -$1.03M – 2702
2017
Q3 		$1.03M Buy
+68,658
New +$644K 0.05% 437

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial's KURA Position: Q1 2026 in Review

Virtu Financial reduced its Kura Oncology (KURA) stake by 8.9% in Q1 2026, selling an estimated $25.6K and leaving 30,615 shares worth $249K. The position accounts for 0.01% of the portfolio, ranked #910.

Virtu Financial first reported a position in KURA in Q3 2017 and has held it in 7 quarters since. The position peaked at $1.03M in Q3 2017. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Virtu Financial held 30,615 shares of Kura Oncology worth $249K as of Q1 2026.
  • Virtu Financial sold 2,976 Kura Oncology shares in Q1 2026, an estimated $25.6K.
  • Kura Oncology made up 0.01% of Virtu Financial's portfolio in Q1 2026, its #910 holding.
  • Virtu Financial first reported a position in Kura Oncology in Q3 2017 and has held it in 7 quarters since.
  • Virtu Financial's Kura Oncology position peaked at $1.03M in Q3 2017.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.